乳腺癌的心脏毒性 化疗 化疗
Sacha A Roberts1, William H Frishman1
1From the Department of Medicine, NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY.
Cardiology in review
|September 4, 2023
概括
本综述检查了乳腺癌治疗方法 (如 antracyclines 和 HER2 抗剂) 的心脏毒性. 它讨论了在患者中监测和预防化疗诱导的心脏功能障碍.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳腺癌是女性恶性瘤的主要原因.
- 有效的治疗方法往往会产生显著的副作用.
- 化疗剂可以引起心肌组织毒性.
研究的目的:
- 审查有关特定乳腺癌病原体心脏毒性的文献.
- 讨论心脏损伤的监测和预防策略.
- 为医疗提供者和患者提供与治疗相关的心脏风险的信息.
主要方法:
- 现有研究的文献综述.
- 综合报告的关于心脏毒性的数据.
- 对监测和预防指南的分析.
主要成果:
- 人环素和HER2抗剂与心脏毒性有关.
- 心脏毒性可以表现为心脏损伤和功能障碍.
- 监测协议和预防措施至关重要.
结论:
- 了解心脏毒性对于乳腺癌患者的护理至关重要.
- 积极的监测和预防可以减轻心脏风险.
- 进一步的研究可能会改进管理策略.
相关概念视频
Heart Failure Drugs: Inotropic Agents
618
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
618
Cardiomyopathy VI: Nursing Management
13
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Pericarditis IV: Nursing Management
20
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
20
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12


